|
|
| Article |
Antigens evaluated |
|
CD30+ anaplastic large-cell lymphoma with aberrant
expression of CD13: case report and review of the literature. |
CD13, CD30, CD45, HLA-DR |
|
CD13-positive anaplastic large cell lymphoma of T-cell origin--a diagnostic and histogenetic problem. |
CD3, CD4, CD5, CD7, CD8, CD10, CD13, CD14, CD15, CD19, CD22, CD30, CD33, CD34, CD45, CD45RO, CD68, K, L, Alk-1, HLA-DR, EMA, Desmin, Vimentin, Lyzozyme, S100, Myeloperoxidase |
|
Cytokeratin in anaplastic large cell lymphoma. |
CAM 5.2, M20, MAK 6, and KS-B17.2 |
|
Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T-
and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. |
CD4, CD8, CD56, CD57, Perforin, TIA-1 |
|
Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. |
CD2, CD3, CD4, CD5, CD7, CD8, CD13, CD14, CD15, CD19, CD20, CD22, CD30, CD36, CD45, Alk, HKLA-DR |
|
CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis. |
CD15, CD30, CD45, CD45RO, EMA, ALK |
|
Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. |
CD20, CD30, CD45, CD45RA, CD45RO, Cytokeratin |
|
Immunoreactivity of CD99 in
non-Hodgkin's lymphoma: unexpected frequent
expression in ALK-positive anaplastic large
cell lymphoma. |
CD99 |
|
